A. Proteau-Gagné et al. / Tetrahedron Letters 52 (2011) 6603–6605
6605
Table 1
Kinetic deconjugation of a variety of substrates
Substrate
Side chain (R)
Corresponding dipeptide
Yielda (%)
10
11
12
–CH2Ph
–CH2OTBDPS
–H
Phe-Gly
Ser-Gly
Gly-Gly
66
63
27c
13
14
–CH2CH2–
Pro-Gly
Ser-Gly
46
–C(CH3)2O–b
47c
a
b
c
Isolated (E) alkene yield.
Serine is protected with a cyclic dimethyl acetal (Garner).
43% (Z) b, -Unsaturated ester product was isolated for 12 and 24% for 14.
c
3. Tomita, K.; Oishi, S.; Ohno, H.; Peiper, S. C.; Fujii, N. J. Med. Chem. 2008, 51,
7645–7649.
4. Proteau-Gagne, A.; Bournival, V.; Rochon, K.; Dory, Y. L.; Gendron, L. ACS Chem.
Neurosci. 2010, 1, 757–769.
5. Gardner, R.; Liang, G.; Gellman, S. J. Am. Chem. Soc. 1999, 121, 1806–1816.
6. Oishi, S.; Kamano, T.; Niida, A.; Odagaki, Y.; Hamanaka, N.; Yamamoto, M.;
Ajito, K.; Tamamura, H.; Otaka, A.; Fujii, N. J. Org. Chem. 2002, 67, 6162–6173.
7. (a) Kranz, M.; Kessler, H. Tetrahedron Lett. 1996, 37, 5359–5362; (b) Otaka, A.;
Yukimasa, A.; Watanabe, J.; Sasaki, Y.; Oishi, S.; Tamamura, H.; Fujii, N. Chem.
Commun. 2003, 1834–1835; (c) Charrier, C.; Ettouati, L.; Paris, J. Tetrahedron
Lett. 1999, 40, 5705–5707; (d) Vasbinder, M. M.; Miller, S. J. J. Org. Chem. 2002,
67, 6240–6242.
8. (a) Guha, S. K.; Shibayama, A.; Abe, D.; Ukaji, Y.; Inomata, K. Chem. Lett. 2003,
32, 778–779; (b) Ikeda, Y.; Ukai, J.; Ikeda, N.; Yamamoto, H. Tetrahedron Lett.
1987, 43, 743–753.
9. Scarso, A.; Delelaen, J.; Viville, R.; De Cock, E.; Van Marsenille, M.; Van Der
Auwera, L.; Tourwé, D.; Van Binst, G. Bull. Soc. Chim. Belg. 1991, 100, 381–395.
10. Tourwe, D.; Couder, J.; Ceusters, M.; Meert, D.; Burks, T. F.; Kramer, T. H.; Davis,
P.; Knapp, R.; Yamamura, H. I.; Leysen, J. E.; Van Binst, G. Int. J. Pept. Protein Res.
1992, 39, 131–136.
The synthetic strategy shown in Scheme 3 could be used to ob-
tain TADIs bearing other functional groups than methyl. A wide
selection of commercial electrophiles can be used in the alkylation
step. Following the same synthetic pathway, a variety of TADIs
could be obtained. The alkylation step could be carried out earlier
in the synthesis by alkylating the diazoketone. This could provide
milder conditions with the use of KHMDS instead of LDA.16
In summary, this synthetic method using kinetic deconjugation
is an efficient way to obtain Xxx-Gly EADIs. We have shown that a
few high yield steps are required to obtain gram quantities of Tyr-
Gly EADI using commercially available starting material. The meth-
od was applied on different amino acids and on the synthesis of
CH3-ADI with successful results. Although we believe this method
could lead to more complex EADIs and TADIs, further investiga-
tions are required to evaluate its full scope.
11. Shi, K.; Harrison, B. A.; Verdine, G. L. Org. Lett. 2003, 5, 633–636.
12. Kinetic deconjugation general protocol: n-BuLi (20 mL, 1.6 M in hexane,
31.2 mmol) was slowly added to DiPA (6 mL, 41.6 mmol) at À20 °C under an
Ar atmosphere, and the mixture was stirred for 30 min at À20 °C. The reaction
was cooled to a temperature of À78 °C, and anhyd THF (20 mL) was added,
Acknowledgment
This work has been supported by the Canadian Institute for
Health Sciences (CIHR) Grant No. MOP-102612 awarded to B.G.,
L.G. and Y.L.D. L.G. is the recipient of a Fonds de la Recherche en
Santé du Québec Junior 2 salary support.
then the conjugated ester
3 (4.05 g, 10.4 mmol), dissolved in anhyd THF
(100 mL), was added over a 15 min period. The reaction mixture was stirred for
30 min at À78 °C and the reaction was quenched rapidly with HCl 1 N
(120 mL). When the mixture was at rt, a saturated solution of NH4Cl was
added, then brine, and the mixture was extracted with ethyl ether
(4 Â 200 mL). The organic layers were combined, dried with MgSO4, filtered,
evaporated under reduced pressure and purified by flash chromatography on
silica gel eluting with EtOAc and hexane (from 3:17 to 1:4 to 1:3) to afford the
title compound as a yellowish oil (3.36 g, 83%).
Supplementary data
Supplementary data (experimental procedures and spectral
data) associated with this article can be found, in the online ver-
13. Anne, C.; Blommaert, A.; Turcaud, S.; Martin, A.-S.; Meudal, H.; Roques, B. P.
Bioorg. Med. Chem. 2003, 11, 4655–4660.
14. Katzenellenbogen, J. A.; Crumrine, A. L. J. Am. Chem. Soc. 1976, 98, 4925–4935.
15. (a) Su, X.; Bhongle, N. N.; Pflum, D.; Butler, H.; Wald, S. A.; Bakale, R. P.;
Senanayake, C. H. Tetrahedron: Asymmetry 2003, 14, 3593–3600; (b) Perrault,
W. R.; Shephard, K. P.; LaPean, L. A.; Krook, M. A.; Dobrowolski, P. J.; Lyster, M.
A.; McMillan, M. W.; Knoechel, D. J.; Evenson, G. N.; Watt, W.; Pearlman, B. A.
Org. Process Res. Dev. 1997, 1, 106–116; (c) Proctor, L. D.; Warr, A. J. Org. Process
Res. Dev. 2002, 6, 884–892.
References and notes
1. Spatola, A. Chemistry and Biochemistry of Amino Acids, Peptides and Proteins;
Marcel Dekker: New York, 1983.
2. Tamamura, H.; Koh, Y.; Ueda, S.; Sasaki, Y.; Yamasaki, T.; Aoki, M.; Maeda, K.;
Watai, Y.; Arikuni, H.; Otaka, A.; Mitsuya, H.; Fujii, N. J. Med. Chem. 2003, 46,
1764–1768.
16. Yang, H.; Foster, K.; Stephenson, C. R. J.; Brown, W.; Roberts, E. Org. Lett. 2000,
2, 2177–2179.